A Cancer Research UK phase I/IIa trial of BT1718 (a first in class Bicycle Toxin Conjugate) given intravenously in patients with advanced solid tumours
Authors
Banerji, UCook, Natalie
Evans, J
Candilejo, M
Roxburgh, P
Kelly, Claire
Sabaratnam, N
Passi, R
Leslie, S
Katugampola, S
Godfrey, L
Tremayne, N
Halbert, G
Bennett, G
Koehler, M
Langford, G
Pittman, M
Symeonides, S
Affiliation
Cancer Research UK Cambridge Institute, CambridgeIssue Date
2018